Navigation Links
Clostridium difficile Infection: Tracking a Virulent Pathogen
Date:8/13/2009

zes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment, leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
2. Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
3. Transmission of MRSA and Clostridium difficile through dogs
4. Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
5. Interview with GI Experts: Discussions in Clostridium difficile
6. Clostridium difficile Infection: Best Strategies for Care of Older Adults
7. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
8. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
9. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
10. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
11. MRSA and C. difficile Infections Reduced by 50% in Hospital Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...l cancer also can reverse a rare stomach disorder ...e disease, researchers at Vanderbilt University Me...e causes thickening of the stomach lining, severe ...emia and swelling in the feet and ankles due to pr...tric cancer. Previously, the only effective treatm...
(Date:11/25/2009)...skin kill tumor cells, study finds , , W...cine delivered in a fingernail-size implant elimin... , The method uses polymer disks, 8.5 millimete...c antigens and implanted under the skin to reprogr... University scientists who developed the implant p...
(Date:11/25/2009)...wide Imaging Services, known as one of the largest...aging equipment, now offering a total solution for..., service and installation with acquisition of Kos...of California) , Brick, N...Services is proud to announce its acquisition of K...
(Date:11/25/2009)...ce.com, the premier resource for life science care... the BioForest™ Hotbed Campaign this morning... November 25, 2009 -- BioSpace.com, the premier re...nveiled the third edition of the BioForest™ ...al campaign is a promotional effort highlighting b...
(Date:11/25/2009)...RecordsSafely,ImproveCare ,, WASHINGTON,Nov.2...ffairs(VA)andKaiserPermanentetodayannouncedanexcit...ion,sheroes.VAandKaiserPermanentearelaunchingapilo...mationusingtheNationwideHealthInformationNetwork(N.... ,, "Theabilitytosharecriticalhealthinformatio...
Breaking Medicine News(10 mins):Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2
...s of the terrible 'Elephant Man' clinical trial we...rate.// The drug, a monoclonal antibody was TG...le sclerosis and rheumatoid arthritis. Confidentia...his 'reckless' mistake probably explained the disa...
...thy adults have had only three vaccines to keep tr...us-diphtheria (Td) booster.// But now two new vacc...6 issue of Harvard Men’s Health Watch. Shingl...ckenpox, the virus remains dormant and harmless fo...
...Center in Oregon is providing healthy organic food...ing habits.// Foods from wild salmon to local orga...ed with a topping of antioxidant-rich dried cherri... "Oh man it was good." The naturally lean bison, p...
...ton University School of Medicine say in a new stu...ldren abuse alcohol and drugs. //In a survey of 59...at parents underestimated the level of their child... found in the journal Alcoholism: Clinical & Exper...
... their enterprise and dedication, have led their f...sole bread earners with their men content to play/...age 'Behind every successful man, there is a woman...uring which I met around 200 people from Kerala se...
...t has blamed the resurgence of polio in India on "...polio vaccine (OPV) used// for its eradication. ... - four-and-a-half times that of last year. Appear... Thekakkara Jacob John, an authority on childhood ...
Other Medicine News:Health News:Catastrophic Elephant Man Drug Trial Victims Injected Recklessly 2Health News:Malayali Nurses - Lifeline of Keralites Abroad 2Health News:Malayali Nurses - Lifeline of Keralites Abroad 3Health News:Polio Outbreak in India due to Vaccine Failure, Says Expert 2
(Date:11/25/2009)...,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswi... HTWR ;ASX:HIN),aleadinginnovatorandproviderofless...srevolutionizingthetreatmentofadvancedheartfailure...esentationatthe21stAnnualPiperJaffrayHealthCareCon...nferenceisbeingheldattheNewYorkPalaceHotel,Decembe...
(Date:11/24/2009)...,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WHA...23yearsfollowinganautoaccident,wasactuallyfullycon...dMorningAmericasegment.TheDynaVoxEyeMaxwasfeatured...romeandotherconditionscanunlockcommunication. ,...ilableonlineat www.dynavoxtech.com ,, WH...
(Date:11/24/2009)...,, FREMONT,Calif.,Nov.24/PRNewswire-FirstCal...edtheCompanyfileditsPlanofReorganizationandDisclos...tesBankruptcyCourtfortheDistrictofDelaware.Ahearin...ntlyscheduledforDecember8,2009,withthehearingonthe..., ThePlancallsfortheCompanytopayallclaimsinfull....
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Healing Depression The Mind Body Way Aims to Depression Proof Your Life 51665 1Healing Depression The Mind Body Way Aims to Depression Proof Your Life 51665 2Stopping harmful oral bacteria in its path is goal for Case Western Reserve researcher 51661 1Stopping harmful oral bacteria in its path is goal for Case Western Reserve researcher 51661 2Surviving mass extinction by leading a double life 9262 1Surviving mass extinction by leading a double life 9262 2
...LAND ,CAUSES, PROMOTES CAMPAIGN TO ITS 12...TV,s Staying Alive,Foundation, SpinVox and Causes ...int campaign, ,Stand By What You Say,. The groundb...k openly about sex, sexual health,and HIV/AIDS, wi...n the,stigma and discrimination which so often acc...
.../S (OMX:,GEN) announced today a Phase I/II study t...of ofatumumab (HuMax-CD20(R)) in rheumatoid arthri...initiated soon. The study, which,will consist of t...ll be,conducted by GlaxoSmithKline., "The additio...mumab is,a great addition to the ofatumumab develo...
Other Medicine Technology:MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand By What You Say' 2MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand By What You Say' 3MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand By What You Say' 4Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study 2Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study 3
Cylindrical Sponge Implants - 5.0 x 80 mm
Double Tantalum Clip (250 Style)
Silicone Sleeve (270 Style)
Meridional Implant (103 Style)
Medicine Products: